RXST logo

RxSight (RXST) Depreciation And Amortization

RXST Annual D&A

$4.24 M
+$221.00 K+5.49%

31 December 2023

RXST Depreciation And Amortization Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RXST Quarterly D&A

$1.14 M
+$321.00 K+39.15%

30 September 2024

RXST Quarterly D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RXST TTM D&A

$4.18 M
+$11.00 K+0.26%

30 September 2024

RXST TTM D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RXST Depreciation And Amortization Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+5.5%+5.3%-1.4%
3 y3 years+5.8%+5.3%-1.4%
5 y5 years+8.0%+5.3%-1.4%

RXST Depreciation And Amortization High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+6.4%at high+39.1%-4.5%+5.4%
5 y5-yearat high+8.0%at high+39.1%-4.5%+339.1%
alltimeall timeat high+8.0%at high+39.1%-4.5%+339.1%

RxSight Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sept 2024
-
$1.14 M(+39.1%)
$4.18 M(+0.3%)
June 2024
-
$820.00 K(-28.1%)
$4.17 M(-4.8%)
Mar 2024
-
$1.14 M(+5.2%)
$4.38 M(+3.3%)
Dec 2023
$4.24 M(+5.5%)
$1.08 M(-4.1%)
$4.24 M(+3.0%)
Sept 2023
-
$1.13 M(+9.7%)
$4.12 M(+3.8%)
June 2023
-
$1.03 M(+3.1%)
$3.97 M(-0.4%)
Mar 2023
-
$999.00 K(+4.0%)
$3.99 M(-0.9%)
Dec 2022
$4.02 M
$961.00 K(-1.9%)
$4.02 M(-1.4%)
Sept 2022
-
$980.00 K(-6.3%)
$4.08 M(-0.7%)
June 2022
-
$1.05 M(+1.1%)
$4.11 M(+1.3%)
DateAnnualQuarterlyTTM
Mar 2022
-
$1.03 M(+1.6%)
$4.06 M(+1.7%)
Dec 2021
$3.99 M(-0.6%)
$1.02 M(+0.9%)
$3.99 M(+0.6%)
Sept 2021
-
$1.01 M(+1.7%)
$3.96 M(-1.7%)
June 2021
-
$993.00 K(+2.8%)
$4.03 M(+0.2%)
Mar 2021
-
$966.00 K(-2.9%)
$4.03 M(+0.3%)
Dec 2020
$4.01 M(+2.1%)
$995.00 K(-7.8%)
$4.01 M(+33.0%)
Sept 2020
-
$1.08 M(+9.5%)
$3.02 M(+55.7%)
June 2020
-
$985.00 K(+3.4%)
$1.94 M(+103.4%)
Mar 2020
-
$953.00 K
$953.00 K
Dec 2019
$3.93 M
-
-

FAQ

  • What is RxSight annual depreciation & amortization?
  • What is the all time high annual D&A for RxSight?
  • What is RxSight annual D&A year-on-year change?
  • What is RxSight quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for RxSight?
  • What is RxSight quarterly D&A year-on-year change?
  • What is RxSight TTM depreciation & amortization?
  • What is the all time high TTM D&A for RxSight?
  • What is RxSight TTM D&A year-on-year change?

What is RxSight annual depreciation & amortization?

The current annual D&A of RXST is $4.24 M

What is the all time high annual D&A for RxSight?

RxSight all-time high annual depreciation & amortization is $4.24 M

What is RxSight annual D&A year-on-year change?

Over the past year, RXST annual depreciation & amortization has changed by +$221.00 K (+5.49%)

What is RxSight quarterly depreciation & amortization?

The current quarterly D&A of RXST is $1.14 M

What is the all time high quarterly D&A for RxSight?

RxSight all-time high quarterly depreciation & amortization is $1.14 M

What is RxSight quarterly D&A year-on-year change?

Over the past year, RXST quarterly depreciation & amortization has changed by +$57.00 K (+5.26%)

What is RxSight TTM depreciation & amortization?

The current TTM D&A of RXST is $4.18 M

What is the all time high TTM D&A for RxSight?

RxSight all-time high TTM depreciation & amortization is $4.38 M

What is RxSight TTM D&A year-on-year change?

Over the past year, RXST TTM depreciation & amortization has changed by -$58.00 K (-1.37%)